Home › Funds › RD Lewis Holdings, Inc. › ABT

RD Lewis Holdings, Inc. position in ABT

ABBOTT LABORATORIES · Health Care

RD Lewis Holdings, Inc. reported holding 13,493 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 1.02% of its reported portfolio and ranking #34 among its reported holdings. RD Lewis Holdings, Inc. has disclosed ABT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)13.49K sh
Reported value held$1.37M
Portfolio Weight1.02%
First reportedQ4 2024
Last changeReduce
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How RD Lewis Holdings, Inc.'s ABT position evolved

RD Lewis Holdings, Inc. first disclosed a stake in ABT in Q4 2024 at 9,790 shares (US$1.3M). The position peaked in Q2 2026 at 14,410 shares, worth US$1.6M. Across 8 filings, RD Lewis Holdings, Inc. increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 13,493 shares valued at US$1.4M — a reduction of -917 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2024 9.79K $1.26M New
Q1 2025 10.61K $1.41M Add
Q2 2025 11.32K $1.50M Add
Q3 2025 11.85K $1.53M Add
Q4 2025 12.95K $1.41M Add
Q1 2026 12.72K $1.31M Reduce
Q2 2026 14.41K $1.58M Add
Q3 2026 13.49K $1.37M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has RD Lewis Holdings, Inc. held ABT?

RD Lewis Holdings, Inc. has disclosed ABT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is RD Lewis Holdings, Inc.'s current position in ABT?

As of Q3 2026, RD Lewis Holdings, Inc. holds 13.49K shares of ABT (ABBOTT LABORATORIES), valued at $1.37M, representing 1.02% of its reported portfolio and ranking #34.

Has RD Lewis Holdings, Inc. been buying or selling ABT?

In the latest 13F filing (Q3 2026), RD Lewis Holdings, Inc. reduced its position in ABT. The position peaked in Q2 2026 at 14.41K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.